HLB PHARMACEUTICAL CO., LTD. · 에이치엘비제약(주)
Last · KOSDAQ₩27050.00+20350.00 (+303.73%)stale · yahoo · 19627h ago
Vol 564.3K ≈ 6.42B
MA10MA20MA50
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
₩6000.00₩22250.00
Volume—session
Issuer
Legal nameHLB PHARMACEUTICAL CO., LTD. · 에이치엘비제약(주)
HQSouth Korea (KR)
ListingKO 047920
ISINKR7047920004
SectorHealthcare
IndustryPharmaceuticals
CurrencyKRW
Entity registrydart:00336817
Org ID00336817
Websitewww.hlbpharma.co.kr
AddressHLB Pharmaceutical Co., Ltd. 27 Gyeonggang-ro 12244, Namyangju
| Revenue | ₩220.9B |
|---|---|
| Operating income | ₩2.8B |
| Net income | ₩3.6B |
| Free cash flow | ₩-4.3B |
| Operating margin | 1.3% |
| Net margin | 1.6% |
| Return on equity | 2.8% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
ANNUAL · 2026-03-19
From latest ANNUAL · 2026-03-19
- Cash Runway Low
Red flags
- Cash Runway Low — Cash runway ~1.1 years
Documents
FormReporting forFiledFlags
Showing 5 of 94 filings